DILTZAC Drug Patent Profile
✉ Email this page to a colleague
When do Diltzac patents expire, and what generic alternatives are available?
Diltzac is a drug marketed by Apotex and is included in one NDA.
The generic ingredient in DILTZAC is diltiazem hydrochloride. There are twenty-six drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the diltiazem hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Diltzac
A generic version of DILTZAC was approved as diltiazem hydrochloride by TEVA on May 31st, 1995.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DILTZAC?
- What are the global sales for DILTZAC?
- What is Average Wholesale Price for DILTZAC?
Summary for DILTZAC
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 58 |
| DailyMed Link: | DILTZAC at DailyMed |
US Patents and Regulatory Information for DILTZAC
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex | DILTZAC | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 076395-001 | Feb 1, 2006 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Apotex | DILTZAC | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 076395-004 | Feb 1, 2006 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| Apotex | DILTZAC | diltiazem hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 076395-002 | Feb 1, 2006 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
